The German laboratory BioNTech is about to file in the EU an authorization request for the use of its vaccine against Covid-19 in children aged 12 to 15 years, making possible an approval from June.
To discover
Covid-19: instructions for use of self-tests
Read also: Why should children be vaccinated to do without barrier gestures
"
In Europe, we are in the final stages before submitting
" the clinical trial data to the European Medicines Agency (EMA) and validation should take between four and six weeks, said the co-founder and director of the company in German magazine
Spiegel
.
